Biocartis is an innovative molecular diagnostics company committed to revolutionize molecular testing with its unique proprietary IdyllaTM platform. We provide next generation diagnostic solutions aimed at improving clinical practice for the benefit of patients, clinicians, payers and the healthcare industry, with a focus on oncology.
Biocartis’ proprietary molecular diagnostics (MDx) IdyllaTM platform is a fully automated sample-to-result, real-time PCR system that offers accurate, highly reliable molecular information from virtually any biological sample, in virtually any setting, allowing fast and effective treatment selection and treatment progress monitoring.
Upcoming eventsAll events
KNOWLEDGE FOR GROWTH 2023Event by: flanders.bio
BIO International Convention 2023Event by: Biotechnology Innovation Organisation
Innovation for Health 2023Event by: Hyphen Projects
Jobs by BiocartisMore jobs
R&D Project Manager